Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2003
04/22/2003US6551607 Method for sequestration of skin irritants with substrate compositions
04/22/2003US6551605 Diesters or polyesters of naphthalene dicarboxylic acid as solubilizer/stabilizer for retinoids
04/22/2003US6551590 Preferred hyaluronidase enzyme is devoid of molecular weight fractions below 40,000 MW, between 60-70,000 MW and above 100,OOO MW
04/22/2003US6551584 Topical antibiotic composition for treatment of eye infection
04/22/2003US6551578 Stability, aerosols, drug delivery; therapy
04/22/2003US6551576 Container with multi-phase composition for use in diagnostic and therapeutic applications
04/22/2003US6550955 Process for producing liquid dosage formulations of medicinal compounds on demand from tablets and capsules using a mixing cup with an abrasive interior surface
04/22/2003CA2304784C A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof
04/22/2003CA2292673C Pharmaceutical compositions containing eletriptan hemisulphate
04/22/2003CA2264960C External formulation containing loxoprofen
04/22/2003CA2235243C Method and preparations for stabilizing biological materials by drying methods without freezing
04/22/2003CA2132012C Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
04/22/2003CA2061520C Delivery system for enhanced onset and increased potency
04/22/2003CA1341427C Variants of immunoglobulin gene superfamily member
04/17/2003WO2003031593A2 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
04/17/2003WO2003031581A2 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith
04/17/2003WO2003031477A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
04/17/2003WO2003031475A2 Antibodies against kdr, their production and uses
04/17/2003WO2003031473A1 Leukocyte inactivation module
04/17/2003WO2003031467A2 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
04/17/2003WO2003031466A2 Angiotensin peptide-carrier conjugates and uses thereof
04/17/2003WO2003031464A2 Remodeling and glycoconjugation of peptides
04/17/2003WO2003030992A1 Betaine-containing cosmetics
04/17/2003WO2003030943A1 Compositions comprising hydroxyapatite useful for the administration of therapeutic agents
04/17/2003WO2003030942A1 Pharmaceutical formulation
04/17/2003WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003WO2003030935A2 Adjuvants for nucleic acid vaccines
04/17/2003WO2003030926A1 Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
04/17/2003WO2003030925A1 Angiogenesis drugs
04/17/2003WO2003030920A1 An antispasmodic agent spaced drug delivery system
04/17/2003WO2003030914A1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs)
04/17/2003WO2003030896A1 Use of tazarotene for preparing a nail varnish for treating and/or preventing psoriasis and nail varnish containing same
04/17/2003WO2003030883A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
04/17/2003WO2003030882A1 Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform
04/17/2003WO2003030881A1 Glucan based film delivery systems
04/17/2003WO2003030879A1 Particle immobilized coatings and uses thereof
04/17/2003WO2003030878A2 Galenic microparticulate oral formulation
04/17/2003WO2003030877A1 Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer
04/17/2003WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003WO2003030875A1 Over-coated chewing gum formulations including tableted center
04/17/2003WO2003030872A2 Compositions having a combination of particles for immediate release and for controlled release
04/17/2003WO2003030871A1 Powder processing with pressurized gaseous fluids
04/17/2003WO2003030870A1 Prolonged release biodegradable microspheres and method for preparing same
04/17/2003WO2003030869A1 Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
04/17/2003WO2003030867A2 Method for preparing an interactive compound of an anilide derivative with a porous support by supercritical fluid
04/17/2003WO2003030866A1 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides
04/17/2003WO2003030865A1 Pro-micelle pharmaceutical compositions
04/17/2003WO2003030862A2 Anaesthetic compositions and method for their administration
04/17/2003WO2003030829A2 Liposome-encapsulated insulin formulations
04/17/2003WO2003030793A1 Hydrating nasal gel and applicator
04/17/2003WO2003030649A1 Stabilisation of macroemulsions
04/17/2003WO2003020207A8 Aqueous air foam
04/17/2003WO2003008457A3 Polysaccharidic esters of retinoic acid
04/17/2003WO2003007922A3 Pharmaceutical formulation containing an ltb4 antagonist
04/17/2003WO2002094325A3 Cytotoxic cd44 antibody immunoconjugates
04/17/2003WO2002078728A3 Peptides for the treatment of wound contracture
04/17/2003WO2002076486A3 Histidine-rich glycoprotein
04/17/2003WO2002076426A3 Intravaginal drug delivery devices for the administration of an antimicrobial agent
04/17/2003WO2002076392A3 Thermally reversible water in oil in water emulsions
04/17/2003WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them
04/17/2003WO2002067895A3 Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
04/17/2003WO2002064167A3 Biologically active agents
04/17/2003WO2002058718A3 Use of compositions containing pdgf-bb for promoting angiogenesis
04/17/2003WO2002058694A9 Method of treating hematologic tumors and cancers using beta lapachone
04/17/2003WO2002047704A9 Herbal pharmaceutical compositions for treating immunological disorders
04/17/2003WO2002024891A3 B7-like molecules and uses thereof
04/17/2003WO2002021134A3 Methods of diagnosing breast cancer and screening for modulators
04/17/2003WO2002017881A3 Transdermal pharmaceutical delivery composition
04/17/2003WO2001089494A8 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
04/17/2003WO2001074402A3 Camptothecin conjugates
04/17/2003US20030073852 Anticancer agents
04/17/2003US20030073825 Azalide antibiotic compositions
04/17/2003US20030073820 Hemoglobin conjugate for use in the synthetic blood
04/17/2003US20030073808 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
04/17/2003US20030073807 Bi-directional synthesis of oligoguanidine transport agents
04/17/2003US20030073676 Dissolving in aqueous carrier; antiallergens
04/17/2003US20030073670 Aqueous solution
04/17/2003US20030073667 Solvent system containing mixture of terpene and alkylene glycol ethers
04/17/2003US20030073665 Formulations containing propofol and a sulfoalkyl ether cyclodextrin
04/17/2003US20030073651 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
04/17/2003US20030073642 Methods and formulations for delivery of pharmacologically active agents
04/17/2003US20030073640 Novel compositions for the delivery of negatively charged molecules
04/17/2003US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
04/17/2003US20030073625 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial IB-367 peptides
04/17/2003US20030073619 Branched polyethylenimine
04/17/2003US20030073617 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
04/17/2003US20030073615 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
04/17/2003US20030073594 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water
04/17/2003US20030073127 Novel calcium channel drugs and uses
04/17/2003US20030072814 Topical pharmaceutical composition for the treatment of warts
04/17/2003US20030072810 Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
04/17/2003US20030072809 Introducing a mixture of medicament and excipients comprising crystalline cellulose into high speed agitation granulator and spraying on water or a mixture of ethanol and water as binder solution to produce spherical granule
04/17/2003US20030072808 Immediate release eplerenone compositions
04/17/2003US20030072805 Microgel and external compositions containing the same
04/17/2003US20030072803 For therapy of excess weight, diabetes, high blood lipid level, artherial sclerosis, artherial plaque, the reduction or prevention of gall stones formation, insufficient lean tissue mass, insufficient sensitivity to insulin, and stroke
04/17/2003US20030072801 Pharmaceutical compositions comprising drug and concentration-enhancing polymers
04/17/2003US20030072800 Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation
04/17/2003US20030072797 Pharmaceutical compositions for oral administration
04/17/2003US20030072789 For towelette or wipes useful for feminine cleansing
04/17/2003US20030072783 Administering nitric oxide adduct to a damaged vascular surface, wherein damaged vascular surface is interior surface of a blood vessel in which damage to endothelium or subendothelium, narrowing or stenosis of vessel has occured
1 ... 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 ... 1712